Prevalence, Correlates and Explanatory Models of Cognitive Deficits in Patients with Schizophrenia-A Cross Sectional Study

Overview

Journal Indian J Psychiatry

Specialty Psychiatry

Date 2023 Dec 18

PMID 38108049

Authors

Chithra Uppinkudru

Rajesh Gopalakrishnan

Joseph Noel

Anju Kuruvilla

Affiliations

Soon will be listed here.

Abstract

Background: Schizophrenia may cause significant impairment in social and economic aspects of a patient's life. Current evidence suggests that cognitive deficits may affect the functioning of a person with schizophrenia more than positive or negative symptoms. There is a lack of literature on explanatory models of cognitive deficits in schizophrenia that can influence help-seeking behavior.

Objectives: This study aimed to estimate the prevalence of cognitive deficits and assess their relationship with socio-demographic and clinical characteristics among patients with schizophrenia. We also planned to explore the explanatory models of cognitive deficits in these patients.

Methods: Consecutive outpatients with schizophrenia who met eligibility criteria were recruited after obtaining informed consent. The Addenbrooke's Cognitive Examination Tamil version (ACE III) and Observable Social Cognition - A Rating Scale (OSCARS) and Positive and Negative Symptom Scale (PANSS) were used to assess cognitive functioning and symptom profile, respectively. Beliefs about illness were recorded using the modified Short Explanatory Model Interview (SEMI). Socio-demographic and treatment-related details were collected with a structured proforma. Statistical analysis was done using SPSS for Windows (version 16.0.1).

Results: One hundred and forty patients participated in the study. The prevalence of cognitive deficits was 75.7% using ACE-III scores, 19.3% on OSCARS, and 40% based on subjective reports. Though the majority (81.4%) of patients reported a medical explanatory model for cognitive impairment, a significant number of them (70.7%) also held non-medical models simultaneously.

Conclusion: Cognitive deficits are prevalent in the majority of patients with schizophrenia. Poor test performance on cognitive testing was observed in those with a significant family history. Multiple contradictory explanatory models for the causation of cognitive deficits were reported.

Citing Articles

Association between cognitive function, antioxidants, and clinical variables in Chinese patients with schizophrenia.

Li D, Huang Y, Lu H, Zhou S, Feng S, Li H BMC Psychiatry. 2024; 24(1):912.

PMID: 39696133 PMC: 11654257. DOI: 10.1186/s12888-024-06335-5.

Pharmacist-led Si-care (schizophrenia care) model to improve medication adherence and symptom management in schizophrenia.

Cahaya N, Kristina S, Widayanti A, Green J Explor Res Clin Soc Pharm. 2024; 16:100544.

PMID: 39687446 PMC: 11647222. DOI: 10.1016/j.rcsop.2024.100544.

References

Kern R, Nuechterlein K, Green M, Baade L, Fenton W, Gold J . The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry. 2008; 165(2):214-20. DOI: 10.1176/appi.ajp.2007.07010043. View

Barnett J, Robbins T, Leeson V, Sahakian B, Joyce E, Blackwell A . Assessing cognitive function in clinical trials of schizophrenia. Neurosci Biobehav Rev. 2010; 34(8):1161-77. DOI: 10.1016/j.neubiorev.2010.01.012. View

Rajji T, Ismail Z, Mulsant B . Age at onset and cognition in schizophrenia: meta-analysis. Br J Psychiatry. 2009; 195(4):286-93. DOI: 10.1192/bjp.bp.108.060723. View

Charernboon T, Chompookard P . Detecting cognitive impairment in patients with schizophrenia with the Addenbrooke's Cognitive Examination. Asian J Psychiatr. 2019; 40:19-22. DOI: 10.1016/j.ajp.2019.01.006. View

Lloyd K, Jacob K, Patel V, St Louis L, Bhugra D, Mann A . The development of the Short Explanatory Model Interview (SEMI) and its use among primary-care attenders with common mental disorders. Psychol Med. 1998; 28(5):1231-7. DOI: 10.1017/s0033291798007065. View

Joel D, Sathyaseelan M, Jayakaran R, Vijayakumar C, Muthurathnam S, Jacob K . A biomedical educational intervention to change explanatory models of psychosis among community health workers in South India. Indian J Psychiatry. 2010; 48(3):138-42. PMC: 2932982. DOI: 10.4103/0019-5545.31575. View

Ballesteros A, Sanchez-Torres A, Lopez-Ilundain J, Cabrera B, Lobo A, Gonzalez-Pinto A . Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?. Psychol Med. 2018; 48(13):2247-2256. DOI: 10.1017/S0033291717003774. View

Drusch K, Lowe A, Fisahn K, Brinkmeyer J, Musso F, Mobascher A . Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls. Eur Arch Psychiatry Clin Neurosci. 2012; 263(6):519-27. DOI: 10.1007/s00406-012-0377-9. View

Littlewood R . From categories to contexts: a decade of the 'new cross-cultural psychiatry'. Br J Psychiatry. 1990; 156:308-27. DOI: 10.1192/bjp.156.3.308. View

10.

Fiszdon J, Fanning J, Johannesen J, Bell M . Social cognitive deficits in schizophrenia and their relationship to clinical and functional status. Psychiatry Res. 2012; 205(1-2):25-9. PMC: 3543468. DOI: 10.1016/j.psychres.2012.08.041. View

11.

Burton C, Twamley E . Neurocognitive insight, treatment utilization, and cognitive training outcomes in schizophrenia. Schizophr Res. 2014; 161(2-3):399-402. PMC: 4308482. DOI: 10.1016/j.schres.2014.12.002. View

12.

Bora E . Differences in cognitive impairment between schizophrenia and bipolar disorder: Considering the role of heterogeneity. Psychiatry Clin Neurosci. 2016; 70(10):424-433. DOI: 10.1111/pcn.12410. View

13.

Tamminga C . Domains of dysfunction in schizophrenia: implications for diagnosis. World Psychiatry. 2008; 7(1):34-5. PMC: 2327228. DOI: 10.1002/j.2051-5545.2008.tb00147.x. View

14.

Bora E, Yalincetin B, Akdede B, Alptekin K . Duration of untreated psychosis and neurocognition in first-episode psychosis: A meta-analysis. Schizophr Res. 2017; 193:3-10. DOI: 10.1016/j.schres.2017.06.021. View

15.

Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges J . Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer's disease. Dement Geriatr Cogn Disord. 2013; 36(3-4):242-50. DOI: 10.1159/000351671. View

16.

Heinrichs R, Zakzanis K . Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998; 12(3):426-45. DOI: 10.1037//0894-4105.12.3.426. View

17.

Healey K, Combs D, Gibson C, Keefe R, Roberts D, Penn D . Observable Social Cognition--A Rating Scale: an interview-based assessment for schizophrenia. Cogn Neuropsychiatry. 2015; 20(3):198-221. PMC: 4372484. DOI: 10.1080/13546805.2014.999915. View

18.

Lazare A, Eisenthal S, Wasserman L . The customer approach to patienthood. Attending to patient requests in a walk-in clinic. Arch Gen Psychiatry. 1975; 32(5):553-8. DOI: 10.1001/archpsyc.1975.01760230019001. View

19.

Burton C, Harvey P, Patterson T, Twamley E . Neurocognitive insight and objective cognitive functioning in schizophrenia. Schizophr Res. 2016; 171(1-3):131-6. PMC: 4762729. DOI: 10.1016/j.schres.2016.01.021. View

20.

Noel J, Viswanathan S, Kuruvilla A . Nature and Correlates of Executive Dysfunction in Schizophrenia: An Exploratory Study. Indian J Psychol Med. 2021; 43(1):16-23. PMC: 8295581. DOI: 10.1177/0253717620929494. View